Risa Kagan, MD, FACOG
Risa Kagan, MD, FACOG, CCD, NCMP
Dr. Kagan is a board-certified obstetrician-gynecologist and is a Clinical Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF. After many years in private practice in Berkely CA, she became a founding member of the Sutter East Bay Medical Group (SEBMG) and practiced gynecology and clinical research with the Sutter East Bay Medical Foundation. She is now a menopause consultant for SEBMG and has a women’s health consulting private practice. Dr. Kagan was a principal investigator on women’s health clinical research trials when she was co-medical director of the Foundation for Osteoporosis Research and Education (FORE) in Oakland, CA, then subsequently did menopause related clinical research with the Sutter Health Research Institute. Dr. Kagan is the author of numerous publications in peer reviewed journals and is on the editorial board of Menopause. She is also an ad hoc reviewer for many other peer reviewed journals including Climacteric, Journal of Women’s Health and The Journal of Sexual Medicine.
She is a North American Menopause Society (NAMS) certified Menopause Practitioner (NCMP) and is certified by the International Society of Clinical Densitometry (CCD). She specializes in gynecology, with a special focus on menopause related health issues, bone and female sexual health, and female cancer survivorship. She is actively involved in several professional organizations including NAMS, is a past Board Trustee, Scientific Program Chair and on the current NAMS Scientific Program Committee. She is also an active member of the International Society for the Study of Women’s Sexual Health (ISSWSH) and the International Menopause Society (IMS) and is on the Medical and Scientific Advisory Board of American Bone Health (ABH). She is currently the President of the San Francisco Gyn Society.
Financial relationships
-
Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:AmgenTopic:Advisor (Advisor fees received)Date added:03/20/2023Date updated:03/20/2023Relationship end date:12/31/2021
-
Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:AstellasTopic:Advisor (Advisor fees received)Date added:03/20/2023Date updated:03/20/2023Relationship end date:08/22/2022
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:PfizerTopic:Advisory Board & Speaker (fees received for both)Date added:03/20/2023Date updated:03/20/2023
-
Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:PharmaviteTopic:Advisor (Advisor fees received)Date added:03/20/2023Date updated:03/20/2023Relationship end date:01/23/2023
-
Attribution:SelfType of financial relationship:Other Financial/Material SupportIneligible company:ScynexisTopic:Advisor (Advisor fees received)Date added:03/20/2023Date updated:03/20/2023
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:AvionTopic:Speaker (Speaker fees received)Date added:03/20/2023Date updated:03/20/2023Relationship end date:10/14/2022
-
Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:Carrot FertilityTopic:Medical Advisor (Advisor fees received)Date added:03/20/2023Date updated:03/20/2023
-
Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:American Bone HealthTopic:Medical and Scientific Ad Board (no payment unless a grant for a Webinar)Date added:03/20/2023Date updated:03/20/2023